(Q73323291)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Stigant CE

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Cohen J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Vivera M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Zaltzman JS

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

58-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

Progression of renal insufficiency: role of blood pressure

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Hypertension after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Understanding the nature of renal disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Severe hyperkalemia as a complication of timolol, a topically applied beta-adrenergic antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Posttransplant erythrocytosis: an enigma revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Serum erythropoietin levels after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970302-7

7 January 2021

10.1016/S0272-6386(00)70302-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620545%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference